The del Nido versus cold blood cardioplegia in aortic valve replacement: A randomized trial

Krzysztof Sanetra1, Witold Gerber1, Rajesh Shrestha1

  • 11st Department of Cardiac Surgery, American Heart of Poland, Bielsko-Biała, Poland; Center for Cardiovascular Research and Development, American Heart of Poland, Bielsko-Biała, Poland.

Insights

The del Nido (DN) cardioplegia protocol, requiring a single infusion, showed a significant reduction in ventricular fibrillation during reperfusion compared to cold blood (CB) cardioplegia in aortic valve replacement patients. DN cardioplegia is a viable alternative for cardiac protection.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Anesthesia
  • Cardioprotection

Background:

  • Aortic valve replacement (AVR) necessitates effective myocardial protection strategies.
  • Traditional cold blood (CB) cardioplegia requires multiple infusions during ischemic durations.
  • The del Nido (DN) cardioplegia solution offers a single-infusion approach for potential improved cardioprotection.

Purpose of the Study:

  • To compare the cardioprotective efficacy of single-infusion del Nido (DN) cardioplegia versus multi-infusion cold blood (CB) cardioplegia.
  • To evaluate primary endpoints including electrical cardiac activity, ventricular fibrillation, and myocardial injury markers (troponin, CK-MB).

Main Methods:

  • A randomized trial involving 150 patients undergoing AVR.
  • Patients were assigned to either the del Nido (DN) cardioplegia group (infusion every 90 minutes) or the cold blood (CB) cardioplegia group (infusion every 20-30 minutes or upon observed cardiac activity).
  • Primary endpoints assessed were intraoperative electrical activity, post-reperfusion ventricular fibrillation, and postoperative cardiac enzyme levels at 24 and 48 hours.

Main Results:

  • No significant difference in electrical cardiac activity during crossclamp between DN and CB groups (39.7% vs 45.3%, P=1.0).
  • Significantly lower incidence of ventricular fibrillation post-reperfusion in the DN group (22.7%) compared to the CB group (54.7%, P=.001).
  • Trend towards lower postoperative troponin and CK-MB levels in the DN group, although not statistically significant.

Conclusions:

  • The del Nido cardioplegia protocol is a safe and effective alternative to cold blood cardioplegia for patients undergoing aortic valve replacement.
  • DN cardioplegia demonstrates a significant advantage in reducing ventricular fibrillation during the critical reperfusion phase.
Abstract

Related Concept Videos

Gradient and Del Operator01:14

Gradient and Del Operator

In mathematics and physics, the gradient and del operator are fundamental concepts used to describe the behavior of functions and fields in space. The gradient is a mathematical operator that gives both the magnitude and direction of the maximum spatial rate of change. Consider a person standing on a mountain. The slope of the mountain at any given point is not defined unless it is quantified in a particular direction. For this reason, a "directional derivative" is defined, which is a vector...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Responses to Heat and Cold Stress02:45

Responses to Heat and Cold Stress

Every organism has an optimum temperature range within which healthy growth and physiological functioning can occur. At the ends of this range, there will be a minimum and maximum temperature that interrupt biological processes.
14.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
399
Random Error01:04

Random Error

Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...
9.1K